NCB adds mephedrone precursor 2-Bromo-4-Methylpropiophenone to NDPS controlled list
Synopsis
India's Narcotics Control Bureau has placed a key mephedrone-making chemical under the NDPS Act, requiring all traders and manufacturers to register by 7 August 2026 or face criminal penalties. The move signals a sharpening of India's precursor-level drug enforcement strategy against the rising tide of synthetic stimulant abuse.
Key Takeaways
The NCB has designated 2-Bromo-4-Methylpropiophenone (CAS No.
1451-82-7 ) a controlled substance under the NDPS Act, 1985 .
The Department of Revenue, Ministry of Finance issued the formal notification on 11 March 2026 under the NDPS (Regulation of Controlled Substances) Order, 2013.
The chemical is a primary precursor in the illicit manufacture of mephedrone (4-methylmethcathinone), widely abused across India.
All stakeholders must submit registration applications in Form B to the NCB Zonal Unit by 7 August 2026 .
Entities holding stocks as of 30 June 2026 must disclose inventory in Form X by 10 July 2026 .
Non-compliance after 7 September 2026 will attract penalties under Section 25A of the NDPS Act.
The Narcotics Control Bureau (NCB) has issued a public notice formally alerting manufacturers, traders, importers, exporters, and other stakeholders that 2-Bromo-4-Methylpropiophenone (CAS No. 1451-82-7) has been designated a controlled substance under the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985. The move, effective through a Department of Revenue, Ministry of Finance notification dated 11 March 2026, targets the chemical's growing role as a key precursor in the illicit synthesis of mephedrone (4-methylmethcathinone), a potent psychotropic drug widely abused across India.
Why This Chemical Was Flagged
Mephedrone, a synthetic stimulant classified as a psychotropic substance, has seen a marked rise in abuse across several Indian states. Enforcement agencies identified 2-Bromo-4-Methylpropiophenone as a critical upstream input in its clandestine manufacture. By bringing the precursor under the NDPS (Regulation of Controlled Substances) Order, 2013, authorities aim to choke the supply chain before the drug is ever produced. This is consistent with India's broader shift toward precursor-level interdiction, which has gained traction as a more effective enforcement strategy than targeting finished synthetic drugs alone.
Registration Requirements for Stakeholders
All individuals and entities engaged in the manufacture, distribution, sale, purchase, possession, storage, import, export, or any commercial dealing of the substance — including transactions conducted through websites, social media, or electronic platforms — must now obtain a registration number in Form A from the jurisdictional Zonal Director of the NCB. Registration applications in Form B must be submitted to the concerned NCB Zonal Unit on or before 7 August 2026, to ensure issuance within the statutory 180-day window.
Existing Stock Disclosure Deadline
Entities holding stocks of 2-Bromo-4-Methylpropiophenone as of 30 June 2026 are required to furnish complete inventory details in Form X to the NCB no later than 10 July 2026. This disclosure requirement covers manufacturers, traders, distributors, importers, exporters, and consumers alike.
Penal Consequences After September 2026
The NCB notice carries an explicit warning: any person or entity found dealing with the substance in contravention of the NDPS Act after 7 September 2026 will face strict penal action under Section 25A of the Act. Prescribed forms, detailed procedures, and jurisdictional information are accessible on the NCB Precursors Portal. The enforcement deadline effectively gives the industry a compliance runway of roughly three months from the date of the public notice.
Point of View
But its effectiveness hinges entirely on enforcement bandwidth at the zonal level — historically the weakest link in India's drug-control chain. The 180-day registration window is generous enough for legitimate chemical traders to comply, yet tight enough to flush out grey-market operators who will simply go underground. What the notice does not address is cross-border e-commerce: the chemical is freely listed on international B2B platforms, and India's ability to intercept small-quantity imports ordered through such channels remains limited. The real test of this notification will come in the seizure data six months from September 2026.
NationPress
4 Aug 2026
Frequently Asked Questions
What is 2-Bromo-4-Methylpropiophenone and why has it been controlled?
2-Bromo-4-Methylpropiophenone (CAS No. 1451-82-7) is a chemical compound used as a key precursor in the illicit manufacture of mephedrone, a potent psychotropic stimulant. The NCB has brought it under the NDPS Act, 1985 to disrupt the supply chain for synthetic drugs amid rising mephedrone abuse in India.
What is the registration deadline for businesses dealing in this substance?
All manufacturers, traders, importers, exporters, and other stakeholders must submit registration applications in Form B to their jurisdictional NCB Zonal Unit on or before 7 August 2026. Registration numbers will be issued in Form A within the statutory 180-day period.
What must businesses do if they already hold stocks of the chemical?
Any entity holding stocks of 2-Bromo-4-Methylpropiophenone as of 30 June 2026 must furnish complete inventory details in Form X to the NCB by 10 July 2026. This covers manufacturers, traders, distributors, importers, exporters, and consumers.
What penalties apply for non-compliance after September 2026?
Any person or entity dealing with the substance in violation of the NDPS Act after 7 September 2026 will face strict penal action under Section 25A of the Act. The NCB has warned that online transactions through websites, social media, or electronic platforms are also covered.
Where can stakeholders find the required forms and procedures?
Prescribed forms (Form A, Form B, and Form X), detailed procedures, and jurisdictional information for NCB Zonal Units are available on the NCB Precursors Portal.
